Artificial Intelligence Based Blood Test Market
Request Sample     Request discount  
Request Sample  
Request Discount  
Request Customization  

Global Artificial Intelligence Based Blood Test Market Analysis By Product Type, By Ingredient Source, By Distribution Channel, By Region - Global Forecast Analysis 2025-2032

  • Published Date : 2025-07-23
  • Pages : 300
  • Report Id : 40673
  • Categories : Healthcare

Introduction

The Global Artificial Intelligence-Based Blood Test market is expected to reach a value of approximately USD 874.2 million by 2024, with a projected CAGR of 19.6% from 2025 to 2032. The Artificial Intelligence-Based Blood Test market is transforming the diagnostics landscape by integrating Artificial Intelligence with both invasive and non-invasive blood analysis techniques. These techniques enable faster, more accurate, and earlier disease detection, paving the way for cost-effective healthcare. Artificial Intelligence algorithms analyse large-scale blood dataranging from genomic, proteomic, and metabolomic sourcesto identify biomarkers and predict disease risk. Artificial Intelligence enhances test sensitivity and specificity, reducing false positives while accelerating diagnostic timelines. Artificial Intelligence tools are increasingly being applied across various diagnostic formats, ranging from image-based haematology and bio-impedance detection to optical readings such as Raman spectroscopy. These platforms are especially valuable in handling complex multivariate data, identifying hidden patterns, and minimising diagnostic errors. Artificial Intelligence-Based Blood Tests are driven by sensor technology, the rising adoption of personalised medicine, and global efforts to improve diagnostic accuracy and accessibility.

Key Highlights

  • The global Artificial Intelligence Blood-Based Testing diagnostics market size was exhibited at USD 874.2 million in 2024, growing at a CAGR of 19.6% during the forecast period 2025 to 2032.
  • The global market for AI-based blood testing, including those using interstitial fluid (ISF), is experiencing significant growth, driven by advancements in AI diagnostics and the increasing adoption of wearable biosensors for minimally invasive monitoring.
  • AI-based blood testing for home healthcare is experiencing significant growth with a market share of 24.6% in 2024, due to increasing demand for early disease detection, personalised treatments, and automation in healthcare
  • The Asia-Pacific (APAC) region is experiencing rapid growth with a CAGR of 23.4% from 2025-2032 in the AI-based blood test market, driven by increasing healthcare expenditure, a large patient population, and the adoption of AI technologies.

Global Artificial Intelligence-Based Blood Test Market

Market Dynamics

Artificial Intelligence Blood Tests are Emerging as Key Tools for Monitoring Health Status and Predicting Risk

Artificial Intelligence is one of the most promising fields in transforming diagnostics and blood testing. Researchers at Harvard Medical School developed CHIEF (Clinical Histopathology Imaging Evaluation Foundation), a versatile model that analyses digital slides of tumour tissues with nearly 94% accuracy. The Artificial Intelligence blood tests use machine learning algorithms to analyse biological data, including biomarkers, genomic sequences, proteins, metabolites, and other indicators. Predictive analytics and datasets enable early detection of various diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders. Artificial Intelligence blood tests play a vital role as a proactive tool-improving outcomes, reducing costs, and helping individuals and clinicians make smarter health decisions. Moreover, these tests are increasingly non-invasive, integrating with wearable technologies or smartphone-based sensors. Artificial Intelligence blood tests are redefining the future of diagnostics-making healthcare more predictive, personalised, and accessible.

AI-driven Apps that connect with Diagnostic Hardware via Smartphones are Creating New Possibilities for Real-Time, on-the-go Health Monitoring

The Artificial Intelligence connects with the diagnostics hardware via smartphone, making it easier for us to monitor and manage health. The AI algorithms process the data and is collected by the connected devices, such as biosensors or photoplethysmography tools, to provide instant insights into a persons health. Real-time enables tracking of chronic conditions and receiving personalised health recommendations through their mobile phones. Bluetooth-enabled sensors, smartphone cameras, and data-based analytics make health monitoring convenient, cost-effective, and widely accessible. The advancement of mobile health technology empowers users to take proactive steps towards disease prevention and well-being.

Global Artificial Intelligence-Based Blood Test Market Segmentation

By Technology

  • Spectroscopy-Based
  • Electromagnetic and Radio Frequency Sensing
  • Biosensors
  • Imaging and Computer Vision
  • Machine Learning

Machine Learning represents the largest segment in the AI-based blood testing in 2024. The rapid advancements in deep learning, computer vision, and signal interpretation enable powerful AI algorithms to detect raw signals into actionable insights. Machine Learning enables real-time analysis from wearables, biosensors, and imaging tools, making it scalable and widely adoptable. Machine Learning is used across glucose monitoring, anaemia detection, cardiovascular diagnostics and infectious disease diagnostics, making it grow across multiple diagnostic verticals.

The Biosensors represent the fastest-growing segment in the AI-based blood test with a CAGR of 21.5% during the forecast period. The smartphone-based imaging and wearable biosensors are transforming diagnostics by enabling real-time, non-invasive health monitoring outside traditional clinical settings. This segment is growing due to its portability, affordability, and compatibility in chronic disease management and low-resource settings. The biosensor's ability to provide rapid and accurate results is making it valuable for diagnostics, drug development, and monitoring.

Sample Type

  • Interstitial Fluid
  • Saliva
  • Sweat
  • Optical Readings through Skin
  • Breath Analysis

The optical readings through the skin hold the largest market share in the world. The optical readings through the skin are widely used in smartwatches and fitness wearables for measuring blood oxygen(SpO2), heart rate, and detecting cardiovascular diagnostics. The non-invasiveness, high user adoption, and AI Integration with cost-effectiveness and data compatibility with AI-driven health platforms make it widely adopted for preventive healthcare, contributing to early diagnostics and remote patient monitoring globally.

The Interstitial fluid (ISF) holds the fastest-growing share in the global AI-based blood testing market. The interstitial fluids can be accessed via microneedles, skin patches, and wearable sensors by avoiding the pain and inconvenience of finger pricks. AI integration further enhances by providing real-time data analysis, trend prediction, and personalised alerts. The technology offers users comfort, improved patient compliance, and is ideal for long-term diseases. The combination of AI precision and ISF accessibility is the key driving its growth in chronic disease monitoring and preventive healthcare.

By Application

  • Glucose Monitoring
  • Haemoglobin and Anaemia Detection
  • Cholesterol and Lipid Profiles
  • Infectious Diseases Screening

In 2024, the Glucose Monitoring holds the largest market share of 27.6% in the worldwide AI-based blood testing market. The global rise in diabetes prevalence has raised the demand for non-invasive, continuous glucose monitoring systems powered by artificial intelligence. The use of AI for pattern recognition and predictive alerts is widely adopted. AI-integrated wearables and sensor platforms help in managing diabetes by providing real-time glucose insights through smartphone apps, making it dominant in the AI-based blood testing.

The Infectious Diseases Screening holds the fastest-growing market in the world. AI models are trained to detect disease-specific biomarkers, patterns in blood profiles, and correlate with the clinical data for the early diagnosis. This segment is driven by global efforts towards early detection of diseases (HIV, Hepatitis and malaria), and automated screening. This segment is expanding rapidly, paving the way for proactive disease management and improved patient outcomes.

By End Users

  • Home Healthcare
  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Research Institutes
  • Pharmaceuticals

The Hospitals and Clinics hold the largest market share in the AI-based blood testing market. The widespread infrastructure, high testing volumes, and integration with advanced diagnostics technologies are the key reasons for the rapid diagnosis, personalised treatment, and chronic disease management. The healthcare professionals and the established workflows make the adoption of the AI-enabled tools smoother. Moreover, Hospitals are integrating Hospital Integrating Systems(HIS) and Electronic Health Records(EHRs) with AI diagnostics, enhancing their utility and accuracy.

Home Healthcare holds the largest market share in the artificial intelligence-based blood testing market with a CAGR of 23.7% from 2025 to 2032. The non-invasive and remote diagnostics solutions are driving the demand for the Home Healthcare Settings. The AI-enabled devices connected with wearables, smartphone applications, and cloud-based platforms offer real-time monitoring of chronic diseases, including diabetes, anaemia, and cardiovascular disease, from the comfort of one's own home. This market is quickly developing due to an ageing population, a growing demand for individualised and decentralised treatment, and the cost-effectiveness of avoiding frequent hospital trips. The post-pandemic healthcare shift and rising consumer awareness have accelerated the adoption of at-home AI diagnostics, positioning home healthcare as a significant driver of market growth.

Global Artificial Intelligence-Based Blood Test Market Regional Analysis

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

North America holds the largest market share in the Artificial Intelligence-Based Blood Test, with a market share of 32.78% in 2024. The early adoption of artificial intelligence in diagnostics, strong research and development funding, and a well-established healthcare infrastructure are key drivers of growth in this region. The USA has major companies and start-ups integrating AI with advanced biosensors and smartphone-based platforms for real-time, non-invasive blood analysis. Canada is active in healthcare innovation and the digital health start-ups, which primarily focus on mobile diagnostics. The region benefits from a tech-savvy population, high chronic diseases, and increasing demand to solidify its position in the global market.

Asia-Pacific holds the fastest-growing segment in the Artificial Intelligence-Based Blood Test. The countries like China and India are heavily investing in artificial intelligence and wearable diagnostics. The large populations and affordability make the mobile-based, non-invasive blood testing a practical solution. Countries like Japan and Korea are also investing in smart medical technologies and AI-integrated devices for mass screening and personalised care.

South America, the Middle East, and Africa are a rising market for AI-based blood testing, with a growing interest in digital health and mobile diagnostics. South American countries such as Brazil and Mexico are adopting, owing to a rise in private healthcare, smartphone usage, and initiatives to enhance rural healthcare access. In the Middle Eastern region, particularly the Gulf nations such as the UAE and Saudi Arabia, the government-backed digital health programs and AI investments are driving the industry expansion. Meanwhile, Africa is in the early stages, with an increasing need for low-cost, portable, AI-enabled diagnostic equipment to overcome healthcare gaps.

Prominent Players in the Market

  • Bosch Global Software Technologies Private Limited
  • Grail inc
  • Meta Materials Inc.
  • Forward Edge-AI inc.
  • Quick Vitals
  • CanSense Ltd.
  • Nutrix
  • Gwave
  • Glycosa
  • Scanbo Inc.
  • Nemaura
  • PreEvnt
  • EzeRx
  • Bloods.ai
  • Apollon

The leading companies in the AI-based Blood testing space have adopted diverse strategies for expanding their market. The companies aim to enhance user comfort and reduce dependency on traditional blood draws. The development of non-invasive testing technologies such as wearable sensors, microneedle patches, and smartphone-integrated diagnostics appeals to both clinical users and consumers seeking real-time monitoring. The partnerships with hospitals, research institutes, and tech firms accelerate the product development, clinical validation, and ensure regulatory compliance. The growth in cloud-based platforms and remote health monitoring solutions is supporting a shift towards home healthcare telemedicine. Additionally, the screening of infectious diseases is being prioritised to address global health challenges. These strategies collectively meet the increasing demand for decentralised, AI-based diagnostics.

Recent Developments

  • In January 2025, Bosch unveiled its AI-powered non-invasive Haemoglobin Monitor. It delivers painless haemoglobin results in ~30 seconds through PPG and won a CES Innovation Award, positioning it for use in resource-limited environments.
  • In June 2024, GWave published an independent study in Diabetes Technology & Therapeutics confirming accuracy (MARD 6.7%) across 75 diverse participants, including those with T1D, T2D, and pregnant individuals.


Market Taxonomy

Regional Coverage

1. Executive Summary

1.1. Market Definition

1.2. Market Introduction

1.3. Segmental Analysis (%), 2024

2. Research Methodology

2.1. Data Collection Process

2.2. Data Collection Methodology

2.3. Primary and Secondary Research

2.4. List of Sources

3. Market Forecast

3.1. Market Value Projection 2025 - 2032 (USD Bn) and Y - o - Y Growth (%)

3.2. Incremental $ Opportunity

4. Global Artificial Intelligence - Based Blood Tests Market Analysis By Technology

4.1. Introduction

4.2. Historical Market Size Analysis 2022 - 2024 and Forecast 2025 - 2032 Analysis, By Technology (USD Bn)

4.2.1. Spectroscopy Based

4.2.1.1. Near Infrared

4.2.1.2. Raman Spectroscopy

4.2.1.3. Optical Coherence Tomography

4.2.1.4. Photoacoustic Spectroscopy

4.2.2. Electromagnetic and Radio Frequency Sensing

4.2.2.1. Microwave Sensing

4.2.2.2. Radio Frequency with AI Classification

4.2.3. Bio impedance

4.2.3.1. Electrical Impedance Spectroscopy

4.2.3.2. Bioelectrical Impedance Analysis

4.2.3.3. Electrical Impedance Tomography

4.2.4. Biosensors

4.2.4.1. Wearable

4.2.4.2. Implantable

4.2.5. Imaging and Computer Vision

4.2.5.1. Smartphone Based Imaging

4.2.5.2. Thermal Imaging

4.2.6. Machine Learning

4.2.6.1. Pattern Recognition for health metrics

4.2.6.2. CNN for image interpretation

4.3. Market Attractiveness Analysis By Technology

6. Global Artificial Intelligence - Based Blood Tests Market Analysis By Sample Type

6.1. Introduction

6.2. Historical Market Size Analysis 2022 - 2024 and Forecast 2025 - 2032 Analysis, By Sample Type (USD Bn)

6.2.1 Interstitial Fluid

6.2.2. Saliva

6.2.3. Sweat

6.2.4. Optical Readings Through Skin (PPG)

6.2.5. Breath Analysis

6.3. Market Attractiveness Analysis By Sample Type

7. Global Artificial Intelligence - Based Blood Tests Market Analysis By Application

7.1. Introduction

7.2. Historical Market Size Analysis 2022 - 2024 and Forecast 2025 - 2032 Analysis, By Application (USD Bn)

7.2.1 Glucose Monitoring

7.2.2. Haemoglobin and Anaemia Detection

7.2.3. Cholesterol and Lipid Profiles

7.2.4. Infectious Disease Screening

7.2.4.1. HIV

7.2.4.2. Others

7.3. Market Attractiveness Analysis By Application

8. Global Artificial Intelligence - Based Blood Tests Market Analysis By Blood Test

8.1. Introduction

8.2. Historical Market Size Analysis 2022 - 2024 and Forecast 2025 - 2032 Analysis, By Blood Test(USD Bn)

8.2.1. Routine Diagnostics Test

8.2.1.1. CBC

8.2.1.2. Liver/Kidney function

8.2.1.3. Chronic Disease Management

8.2.1.4. cholesterol and Lipids

8.2.2. Haemoglobin and Anaemia Detection

8.2.2.1. Microwave Sensing

8.2.2.2. Radio Frequency with AI Classification

8.2.3. Bio impedance

8.2.3.1. Electrical Impedance Spectroscopy

8.2.3.2. Bioelectrical Impedance Analysis

8.2.3.3. Electrical Impedance Tomography

8.2.4. Biosensors

8.2.4.1. Wearable

8.2.4.2. Implantable

8.2.5. Imaging and Computer Vision

8.2.5.1. Smartphone Based Imaging

8.2.5.2. Thermal Imaging

8.2.6. Machine Learning

8.2.6.1. Pattern Recognition for health metrics

8.2.6.2. CNN for image interpretation

8.3. Market Attractiveness Analysis By Blood Test

9. Global Artificial Intelligence - Based Blood Tests Market Analysis By Deployment Mode

9.1. Introduction

9.2. Historical Market Size Analysis 2022 - 2024 and Forecast 2025 - 2032 Analysis, By Deployment Mode(USD Bn)

9.2.1. Standalone Devices

9.2.2. Smartphone Connected

9.2.3. Cloud - Synced

9.2.4. Hospital Information Systems

9.3. Market Attractiveness Analysis By Deployment Mode

10. Global Artificial Intelligence - Based Blood Tests Market Analysis By End Users

10.1. Introduction

10.2. Historical Market Size Analysis 2022 - 2024 and Forecast 2025 - 2032 Analysis, By End Users (USD Bn)

10.2.1. Home Healthcare

10.2.2. Hospitals and Clinics

10.2.2. Diagnostics Laboratory

10.2.3. Research Institutes

10.2.4. Pharmaceuticals

10.3. Market Attractiveness Analysis By End Users

11. Global Artificial Intelligence - Based Blood Tests Market Analysis By Region

11.1. Introduction

11.2. Historical Market Size (USD Bn) Analysis 2022 - 2024 By Region

11.3. Market Attractiveness Analysis By Region

12. North America Artificial Intelligence - Based Blood Tests Market Analysis

12.1. Introduction

12.2. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Technology (USD Bn)

12.3. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Sample Type (USD Bn)

12.4. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Application (USD Bn)

12.5. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Blood Test (USD Bn)

12.6. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Deployment Mode (USD Bn)

12.7. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By End Users (USD Bn)

12.8. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Country (USD Bn)

12.8.1. U.S.

12.8.2. Canada

12.8.3. Mexico

12.8.4. Puerto Rico

12.8.5. Rest of North America

13. Europe Artificial Intelligence - Based Blood Tests Market Analysis

13.1. Introduction

13.2. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Technology (USD Bn)

13.3. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Sample Type (USD Bn)

13.4. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Application (USD Bn)

13.5. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Blood Test (USD Bn)

13.6. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Deployment Mode (USD Bn)

13.7. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By End Users (USD Bn)

13.8. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Country (USD Bn)

13.8.1. Germany

13.8.2. Italy

13.8.3. France

13.8.4. UK

13.8.5. Russia

13.8.6. Spain

13.8.7. Switzerland

13.8.8. Belgium

13.8.9. The Netherlands

13.8.10. Rest of Europe

14. Asia - Pacific Artificial Intelligence - Based Blood Tests Market Analysis

14.1. Introduction

14.2. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Technology (USD Bn)

14.3. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Sample Type (USD Bn)

14.4. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Application USD Bn)

14.5. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Blood Test (USD Bn)

14.6. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Deployment Mode (USD Bn)

14.7. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By End Users (USD Bn)

14.8. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Country (USD Bn)

14.8.1. China

14.8.2. India

14.8.3. Japan

14.8.4. South Korea

14.8.5. Singapore

14.8.6. New Zealand

14.8.7. Australia

14.8.8. Rest of Asia - Pacific

15. South America Artificial Intelligence - Based Blood Tests Market Analysis

15.1. Introduction

15.2. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Technology (USD Bn)

15.3. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Sample Type (USD Bn)

15.4. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Application (USD Bn)

15.5. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Blood Test (USD Bn)

15.6. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Deployment Mode (USD Bn)

15.7. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By End Users (USD Bn)

15.8. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Country (USD Bn)

15.8.1. Brazil

15.8.2. Argentina

15.8.3. Columbia

15.8.4. Peru

15.8.5. Chile

15.8.6. Rest of South America

16. Middle East and Africa (MEA) Artificial Intelligence - Based Blood Tests Market Analysis

16.1. Introduction

16.2. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Technology (USD Bn)

16.3. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Sample Type (USD Bn)

16.4. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Application USD Bn)

16.5. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Blood Test (USD Bn)

16.6. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Deployment Mode (USD Bn)

16.7. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By End Users (USD Bn)

16.8. Historic Market Value 2022 - 2024, and Forecast 2025 - 2032, By Country (USD Bn)

16.8.1. Saudi Arabia

16.8.2. UAE

16.8.3. Oman

16.8.4. Qatar

16.8.5. Algeria

16.8.6. Morocco

16.8.7. Libya

16.8.8. South Africa

16.8.9. Turkey

16.8.10. Rest of MEA

17. Market Structure Analysis

17.1. Company Market Share (%) Analysis, 2024

17.2. Tier Structure Analysis, 2024

17.3. Company Strategies Analysis

17.4. SWOT Analysis

18. Competition Analysis

18.1. Competition Dashboard

18.2. Company Profiles (15 Companies)

18.2.1. Bosch Global Software Technologies Private Limited

18.2.1.1. Overview

18.2.1.2. Product/Services Portfolio

18.2.1.3. Financial Overview

18.2.1.4. Recent Developments

18.2.1.5. Key Company Strategies

18.2.2. Grail Inc.

18.2.3. Meta Materials Inc.

18.2.4. Quick Vitals

18.2.5. CanSense Ltd.

18.2.6. Nutrix

18.2.7. GWave

18.2.8. Glycosa

18.2.9. Scanbo Inc.

18.2.10. Nemaura

18.2.11. PreEvnt

18.2.12. EzeRx

18.2.13. Bloods.ai

18.2.14. Apollon

18.2.15. Forward Edge - AI Inc.

19. Economic Scenario: Impacts on the Global Artificial Intelligence - Based Blood Tests Market

19.1. Economic Impact on the Global Artificial Intelligence - Based Blood Tests Market

19.2. Macro - Economic Indicators

20. Market Background

20.1. Key Market Takeaways

20.2. Regulatory Landscape

20.3. Forecast Factors: Relevance and Impact

20.4. Market Dynamics

20.4.1. Drivers

20.4.2. Restraints

20.4.3. Opportunities

20.4.4. Trends

20.4.5. Challenges

20.5. PESTLE Analysis

20.6. Porter's Five Force Analysis

20.7. Technology Roadmap

20.8. Premium Insights

20.8.1. Supply Chain Analysis

20.8.2. New Product Launches By Key Players

21. Analysis and Recommendations

22. Assumptions & Acronyms

List Of Figures:

Figure 01: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Technology, (2024)
Figure 02: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Sample Type, (2024)
Figure 03: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Application, (2024)
Figure 03: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test, (2024)
Figure 04: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Deployment Mode, (2024)
Figure 05: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 06: Global Artificial Intelligence - Based Blood Tests Market Value 2025 - 2032 (USD Bn) and Y - o - Y Growth (2025 - 2032)
Figure 07: Global Artificial Intelligence - Based Blood Tests Market Incremental $ Opportunity (USD Bn), 2025 - 2032
Figure 08: Global Artificial Intelligence - Based Blood Tests Market: Market Attractiveness Analysis, By Technology
Figure 09: Global Artificial Intelligence - Based Blood Tests Market: Market Attractiveness Analysis, By Sample Type
Figure 10: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Application, (2024)
Figure 11: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test, (2024)
Figure 12: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Deployment Mode, (2024)
Figure 13: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 14: Global Artificial Intelligence - Based Blood Tests Market Share Analysis (%), by Region, 2022(H), 2025(E) & 2032(F)
Figure 15: Global Artificial Intelligence - Based Blood Tests Market, Y - O - Y Growth, by Region, 2025(E) 2032(F)
Figure 16: Global Artificial Intelligence - Based Blood Tests Market: Market Attractiveness Analysis, by Region
Figure 17: North America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Technology, (2024)
Figure 18: North America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Sample Type, (2024)
Figure 19: North America Artificial Intelligence - Based Blood Tests Share Analysis (%), By Application, (2024)
Figure 20: North America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test (2024)
Figure 21: North America Artificial Intelligence - Based Blood Tests Share Analysis (%), By Deployment Mode, (2024)
Figure 22: North America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 23: North America Artificial Intelligence - Based Blood Tests Market Value Forecast 2025 & 2032 (USD Bn)
Figure 24: Europe Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Technology, (2024)
Figure 25: Europe Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Sample Type, (2024)
Figure 26: Europe Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Application, (2024)
Figure 27: Europe Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test, (2024)
Figure 28: Europe Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Deployment Mode, (2024)
Figure 29: Europe Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 30: Europe Artificial Intelligence - Based Blood Tests Market Value Forecast 2025 & 2032 (USD Bn)
Figure 31: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Technology, (2024)
Figure 32: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Sample Type, (2024)
Figure 33: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Application, (2024)
Figure 34: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test, (2024)
Figure 35: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Deployment Mode, (2024)
Figure 36: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 37: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value Forecast 2025 & 2032 (USD Bn)
Figure 38: South America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Technology, (2024)
Figure 39: South America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Sample Type, (2024)
Figure 40: South America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Application, (2024)
Figure 41: South America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test, (2024)
Figure 42: South America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Deployment Mode, (2024)
Figure 43: South America Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 44: South America Artificial Intelligence - Based Blood Tests Market Value Forecast 2025 & 2032 (USD Bn)
Figure 45: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Technology, (2024)
Figure 46: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Sample Type, (2024)
Figure 47: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Application, (2024)
Figure 48: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Blood Test, (2024)
Figure 49: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By Deployment Mode, (2024)
Figure 50: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Share Analysis (%), By End Users, (2024)
Figure 51: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value Forecast 2025 & 2032 (USD Bn)
Figure 52: Global Artificial Intelligence - Based Blood Tests Market, Company Market Share (%) Analysis, 2023
Figure 53: Global Artificial Intelligence - Based Blood Tests Market, Tier Structure Analysis, 2023

List Of Tables:

Table 01: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 02: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Sample Type, 2022(H) 2032(F)
Table 03: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Application, 2022(H) 2032(F)
Table 04: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Blood Test, 2022(H) 2032(F)
Table 05: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Deployment Mode, 2022(H) 2032(F)
Table 06: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By End Users, 2022(H) 2032(F)
Table 07: Global Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Region, 2022(H) 2032(F)
Table 08: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 09: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Sample Type, 2022(H) 2032(F)
Table 10: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Application, 2022(H) 2032(F)
Table 11: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Blood Test, 2022(H) 2032(F)
Table 12: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Deployment Mode, 2022(H) 2032(F)
Table 13: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By End Users, 2022(H) 2032(F)
Table 14: North America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Country, 2022(H) 2032(F)
Table 15: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 16: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Sample Type, 2022(H) 2032(F)
Table 17: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Application,2022(H) 2032(F)
Table 18: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Blood Test,2022(H) 2032(F)
Table 19: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Deployment Mode, 2022(H) 2032(F)
Table 20: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By End Users, 2022(H) 2032(F)
Table 21: Europe Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Country, 2022(H) 2032(F)
Table 22: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 23: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Sample Type, 2022(H) 2032(F)
Table 24: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Application, 2022(H) 2032(F)
Table 25: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Blood Test, 2022(H) 2032(F)
Table 26: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Deployment Mode, 2022(H) 2032(F)
Table 27: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By End Users, 2022(H) 2032(F)
Table 28: Asia - Pacific Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Country, 2022(H) 2032(F)
Table 29: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 30: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Sample Type, 2022(H) 2032(F)
Table 31: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 32: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Application,2022(H) 2032(F)
Table 33: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Blood Test, 2022(H) 2032(F)
Table 34: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Deployment Mode, 2022(H) 2032(F)
Table 35: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By End Users, 2022(H) 2032(F)
Table 36: South America Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Country, 2022(H) 2032(F)
Table 37: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 38: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Sample Type, 2022(H) 2032(F)
Table 39: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Technology, 2022(H) 2032(F)
Table 40: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Application, 2022(H) 2032(F)
Table 41: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Blood Test, 2022(H) 2032(F)
Table 42: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Deployment Mode, 2022(H) 2032(F)
Table 43: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By End Users, 2022(H) 2032(F)
Table 44: Middle East and Africa Artificial Intelligence - Based Blood Tests Market Value (USD Bn) and Forecast, By Country, 2022(H) 2032(F)

Immediate acquisition
Your strategic edge begins with Stats and Research
Single User License
$1999
It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
Multi User License
$2399
It allows the purchased product to be shared among 1-5 employees of your organization within same geographical location.
Enterprise User License
$2599
It allows the purchased product to be shared among all employees of your organisation irrespective of their geographical location.
Services
On Demand Reports Subscription Plans Consulting Services ESG Solutions
Global Artificial Intelligence Based Blood Test Market CAGR (%), 2025-2032

CAGR 19.6 %

  View All Healthcare Reports

Global Cellular Products Market

Global Cellular Products Market

Global Blue Light Therapy Device Market

Global Blue Light Therapy Device Market

Global Artificial Intelligence Based Blood Test Market

Global Artificial Intelligence Based Blood Test Market

Global Digital Pills Market

Global Digital Pills Market

Global POC Ultrasound Market

Global POC Ultrasound Market

Global Needle-Free Blood Testing Market

Global Needle-Free Blood Testing Market

Global Medical Tourism Market

Global Medical Tourism Market

Gummy Supplements Market

Gummy Supplements Market

Software As a Medical Device (SaMD) Market

Software As a Medical Device (SaMD) Market

Canada Consumer Healthcare Market

Canada Consumer Healthcare Market

Stats And Research ™ Copyright © 2025 .